Developing a vaccine is a time-consuming and complex process, requiring a combination of specialized skills and technical capacities not readily available at a single organization. To facilitate access to these skills and capacities, TRANSVAC2 offers high-quality technical services to support the development of prophylactic and therapeutic vaccines for both human and animal use. These services are not restricted to any disease area. Services will be offered free of charge, with few exceptions! Academic and non-academic research groups, SMEs and industries can apply!
Submit your application by December 15th, 2020! For further information on services available and how to apply please visit www.transvac.org.
About TRANSVAC2
TRANSVAC2, is a European vaccine research and development (R&D) infrastructure project, coordinated by European Vaccine Initiative, dedicated to accelerating the development of safe, effective and affordable vaccines.
TRANSVAC2 has received funding from the European Union's Horizon 2020 research and innovation program under grant agreement N° 730964.
